Skip to content

Public FDA record

Z-1689-2016: Diamedix Is-CMV IgG Test Kit

Recall record Z-1689-2016 for Diamedix Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1689-2016
Company in FDA record
Diamedix Corporation
FDA record creation date
May 17, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product contained an incorrect substrate.

Source facts

Action
On March 26, 2015 Erba Diagnostics sent a communication to their clients informing them of the recall and sending t hem a replacement sustrate HRP to replaced the wrong one sent on the kit.
Initiated
2015-03-26
Root cause
Other
Terminated
2018-11-14
Distribution
AZ, CA, FL, GA, KY, MA, MI, MN, MO, NC, NE, NY, OH, OK, OR, TN, TX, VA, WI and Puerto Rico.
Recall number
Z-1689-2016
Recall status
Terminated
CDRH record ID
145394
FDA record created
2016-05-17
Recall event number
73194

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗